Ravi Viswanathan's Net Worth
Ravi Viswanathan's net worth is estimated to be at least $2,999,047.14 as of 12/27/2024. CoreStreet's estimation of Ravi Viswanathan's net worth is based on their sale of stock and current holding of stock.
Ravi Viswanathan is Major Shareholder at AVEO Pharmaceuticals Inc. They have executed at least 5 trades of stock as per SEC Form 4 filings. Their most recent trade was for 184,179 units of AVEO stock on 05/17/2018. Their biggest sale was on 02/26/2018 when they sold 1,460,209 units of ARCA Biopharma Inc stock for $730,104.50. They typically trade 5 times per year.
Total value of insider buys:
- $2,268,942.64
Total value of insider sells:
- $730,104.50
Most recent insider trade:
- May 17, 2018
Ravi Viswanathan's Insider Trading History
| AVEO Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 17, 2018 | Major Shareholder | 184,179 | $2.13 | Buy | $392,301.27 |
May 8, 2018 | Major Shareholder | 70,873 | $2.13 | Buy | $150,959.49 |
April 6, 2018 | Major Shareholder | 685,676 | $2.24 | Buy | $1,535,914.24 |
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 21, 2018 | Major Shareholder | 104,844 | $1.81 | Buy | $189,767.64 |
| ARCA Biopharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 26, 2018 | Major Shareholder | 1,460,209 | $0.50 | Sell | $730,104.50 |